Johnson & Johnson has built its presence in KRAS drugs for cancer with a $1bn deal to buy Firefly Bio and its degrader-antibody conjugate platform.
UK offers meningitis jab to young people after outbreak
The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to “thousands” of young people this summer.
